{"transactions":[{"id":692501,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-08-10T10:07:40.000Z","date":"2026-08-05","kind":"sale","planned":false,"acquired":false,"shares":17,"price":34.8655,"value":592.7135,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":73247,"source":{"system":"sec-edgar","filing":"0001193125-26-341086","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526341086/ownership.xml","form_type":"4"}},{"id":747049,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2026-06-08T20:03:06.000Z","date":"2026-06-05","kind":"exercise","planned":false,"acquired":false,"shares":14492,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted share units were granted on June 5, 2025 and vested on June 5, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted share units were granted on June 5, 2025 and vested on June 5, 2026."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":14492},"source":{"system":"sec-edgar","filing":"0001193125-26-261676","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526261676/ownership.xml","form_type":"4"}},{"id":747048,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-06-08T20:03:06.000Z","date":"2026-06-05","kind":"exercise","planned":false,"acquired":true,"shares":14492,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":73264,"source":{"system":"sec-edgar","filing":"0001193125-26-261676","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526261676/ownership.xml","form_type":"4"}},{"id":757995,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2026-06-01T20:16:53.000Z","date":"2026-05-28","kind":"grant","planned":false,"acquired":true,"shares":7242,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted share units were granted on May 28, 2026 and vest on May 28, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted share units were granted on May 28, 2026 and vest on May 28, 2027."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":7242,"derivative":{"underlying":"Ordinary Shares","underlying_shares":7242},"source":{"system":"sec-edgar","filing":"0001193125-26-251459","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526251459/ownership.xml","form_type":"4"}},{"id":1118901,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2025-06-09T20:22:54.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":14492,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Restricted share units were granted on June 5, 2025 and vest on June 5, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Restricted share units were granted on June 5, 2025 and vest on June 5, 2026."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":14492,"derivative":{"underlying":"Ordinary Shares","underlying_shares":14492},"source":{"system":"sec-edgar","filing":"0000950170-25-083769","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017025083769/ownership.xml","form_type":"4"}},{"id":1118900,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2025-06-09T20:22:54.000Z","date":"2025-06-06","kind":"exercise","planned":false,"acquired":false,"shares":9632,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted share units were granted on June 6, 2024 and vested on June 6, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted share units were granted on June 6, 2024 and vested on June 6, 2025."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":9632},"source":{"system":"sec-edgar","filing":"0000950170-25-083769","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017025083769/ownership.xml","form_type":"4"}},{"id":1118899,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-06-09T20:22:54.000Z","date":"2025-06-06","kind":"exercise","planned":false,"acquired":true,"shares":9632,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":58772,"source":{"system":"sec-edgar","filing":"0000950170-25-083769","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017025083769/ownership.xml","form_type":"4"}},{"id":1478065,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2024-06-17T12:03:34.000Z","date":"2024-06-15","kind":"exercise","planned":false,"acquired":false,"shares":21108,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted Share Units were granted on June 15, 2023 and vested on June 15, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted Share Units were granted on June 15, 2023 and vested on June 15, 2024."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":21108},"source":{"system":"sec-edgar","filing":"0000950170-24-074027","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017024074027/ownership.xml","form_type":"4"}},{"id":1478064,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2024-06-17T12:03:34.000Z","date":"2024-06-15","kind":"exercise","planned":false,"acquired":true,"shares":21108,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":49140,"source":{"system":"sec-edgar","filing":"0000950170-24-074027","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017024074027/ownership.xml","form_type":"4"}},{"id":1485684,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2024-06-10T11:51:13.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":9632,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted share units were granted on June 6, 2024 and vest on June 6, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted share units were granted on June 6, 2024 and vest on June 6, 2025."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":9632,"derivative":{"underlying":"Ordinary Shares","underlying_shares":9632},"source":{"system":"sec-edgar","filing":"0000950170-24-071078","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017024071078/ownership.xml","form_type":"4"}},{"id":1814248,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2023-08-07T20:12:11.000Z","date":"2023-08-04","kind":"exercise","planned":false,"acquired":false,"shares":15810,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted share units were granted on August 4, 2022 and vested on August 4, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted share units were granted on August 4, 2022 and vested on August 4, 2023."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":15810},"source":{"system":"sec-edgar","filing":"0001209191-23-044795","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919123044795/doc4.xml","form_type":"4"}},{"id":1814247,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-08-07T20:12:11.000Z","date":"2023-08-04","kind":"exercise","planned":false,"acquired":true,"shares":15810,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."}],"balance_after":28032,"source":{"system":"sec-edgar","filing":"0001209191-23-044795","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919123044795/doc4.xml","form_type":"4"}},{"id":1850672,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2023-06-20T11:39:36.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":21108,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted share units were granted on June 15, 2023 and vest on June 15, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted share units were granted on June 15, 2023 and vest on June 15, 2024."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":21108,"derivative":{"underlying":"Ordinary Shares","underlying_shares":21108},"source":{"system":"sec-edgar","filing":"0001209191-23-038225","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919123038225/doc4.xml","form_type":"4"}},{"id":2123872,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2022-11-07T12:02:03.000Z","date":"2022-11-04","kind":"exercise","acquired":false,"shares":12205,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted share units were granted on November 4, 2021 and vested on November 4, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted share units were granted on November 4, 2021 and vested on November 4, 2022."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":12205},"source":{"system":"sec-edgar","filing":"0001209191-22-055877","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919122055877/doc4.xml","form_type":"4"}},{"id":2123871,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2022-11-07T12:02:03.000Z","date":"2022-11-04","kind":"exercise","acquired":true,"shares":12205,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."}],"balance_after":12222,"source":{"system":"sec-edgar","filing":"0001209191-22-055877","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919122055877/doc4.xml","form_type":"4"}},{"id":2192417,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2022-08-08T11:29:04.000Z","date":"2022-08-04","kind":"grant","acquired":true,"shares":15810,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted share units were granted on August 4, 2022 and vest on August 4, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted share units were granted on August 4, 2022 and vest on August 4, 2023."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":15810,"derivative":{"underlying":"Ordinary Shares","underlying_shares":15810},"source":{"system":"sec-edgar","filing":"0001209191-22-044700","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919122044700/doc4.xml","form_type":"4"}},{"id":2217351,"issuer":{"id":9824,"kind":"organization","name":"Adaptimmune Therapeutics PLC"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Ordinary Shares","published_at":"2022-07-01T21:03:51.000Z","date":"2022-07-01","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price was converted from GBP0.23 based on an exchange rate of $U.S. 1.216007 to GBP1.00. The actual exercise price will be the pounds sterling amount."}],"balance_after":500000,"derivative":{"exercise_price":0.28,"exercise_date":"2023-07-01","expiration_date":"2032-07-01","underlying":"Ordinary Shares","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001104659-22-076901","document":"tm2220260-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690927/000110465922076901/tm2220260-7_4seq1.xml","form_type":"4"}},{"id":2405273,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2022-02-10T21:15:03.000Z","date":"2021-11-19","kind":"other","acquired":true,"shares":17,"price":8.88,"value":150.96,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":17,"source":{"system":"sec-edgar","filing":"0001209191-22-008421","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919122008421/doc5.xml","form_type":"5"}},{"id":2522093,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2021-11-08T21:02:08.000Z","date":"2021-11-04","kind":"grant","acquired":true,"shares":12205,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted share units were granted on November 4, 2021 and vest on November 4, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted share units were granted on November 4, 2021 and vest on November 4, 2022."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":12205,"derivative":{"underlying":"Ordinary Shares","underlying_shares":12205},"source":{"system":"sec-edgar","filing":"0001209191-21-063361","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919121063361/doc4.xml","form_type":"4"}},{"id":2644814,"issuer":{"id":9824,"kind":"organization","name":"Adaptimmune Therapeutics PLC"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Ordinary Shares","published_at":"2021-07-02T21:03:49.000Z","date":"2021-07-01","kind":"grant","acquired":true,"shares":379788,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price was converted from GBP0.51 based on an exchange rate of $U.S. 1.3807 to GBP1.00. The actual exercise price will be the pounds sterling amount."}],"balance_after":379788,"derivative":{"exercise_price":0.71,"exercise_date":"2022-07-01","expiration_date":"2031-07-01","underlying":"Ordinary Shares","underlying_shares":379788},"source":{"system":"sec-edgar","filing":"0001104659-21-088974","document":"tm2121284-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690927/000110465921088974/tm2121284-7_4seq1.xml","form_type":"4"}},{"id":2644813,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-02T20:30:13.000Z","date":"2021-06-30","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 5, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of this option vested and became exercisable on February 28, 2021 with the remainder vesting in twelve (12) equal quarterly installments thereafter."}],"balance_after":121120,"derivative":{"exercise_price":25.93,"expiration_date":"2030-02-28","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001127602-21-021250","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1690927/000112760221021250/form4.xml","form_type":"4"}},{"id":2644812,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-07-02T20:30:13.000Z","date":"2021-06-30","kind":"sale","acquired":false,"shares":5000,"price":237,"value":1185000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 5, 2021."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001127602-21-021250","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1690927/000112760221021250/form4.xml","form_type":"4"}},{"id":2644811,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-07-02T20:30:13.000Z","date":"2021-06-30","kind":"exercise","acquired":true,"shares":5000,"price":25.93,"value":129650.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 5, 2021."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001127602-21-021250","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690927/000112760221021250/form4.xml","form_type":"4"}},{"id":2654804,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-25T21:22:32.000Z","date":"2021-06-23","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 5, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of this option vested and became exercisable on February 28, 2021 with the remainder vesting in twelve (12) equal quarterly installments thereafter."}],"balance_after":126120,"derivative":{"exercise_price":25.93,"expiration_date":"2030-02-28","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001127602-21-020699","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1690927/000112760221020699/form4.xml","form_type":"4"}},{"id":2654803,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-06-25T21:22:32.000Z","date":"2021-06-23","kind":"sale","acquired":false,"shares":5000,"price":219.65,"value":1098250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 5, 2021."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001127602-21-020699","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1690927/000112760221020699/form4.xml","form_type":"4"}},{"id":2654802,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-06-25T21:22:32.000Z","date":"2021-06-23","kind":"exercise","acquired":true,"shares":5000,"price":25.93,"value":129650.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 5, 2021."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001127602-21-020699","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690927/000112760221020699/form4.xml","form_type":"4"}},{"id":2661064,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-21T23:03:44.000Z","date":"2021-06-16","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 5, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of this option vested and became exercisable on February 28, 2021 with the remainder vesting in twelve (12) equal quarterly installments thereafter."}],"balance_after":131120,"derivative":{"exercise_price":25.93,"expiration_date":"2030-02-28","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001127602-21-020449","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1690927/000112760221020449/form4.xml","form_type":"4"}},{"id":2661063,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-06-21T23:03:44.000Z","date":"2021-06-16","kind":"sale","acquired":false,"shares":5000,"price":200,"value":1000000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 5, 2021."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001127602-21-020449","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1690927/000112760221020449/form4.xml","form_type":"4"}},{"id":2661062,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-06-21T23:03:44.000Z","date":"2021-06-16","kind":"exercise","acquired":true,"shares":5000,"price":25.93,"value":129650.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 5, 2021."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001127602-21-020449","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690927/000112760221020449/form4.xml","form_type":"4"}},{"id":2672057,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-11T20:14:03.000Z","date":"2021-06-09","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 5, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of this option vested and became exercisable on February 28, 2021 with the remainder vesting in twelve (12) equal quarterly installments thereafter."}],"balance_after":136120,"derivative":{"exercise_price":25.93,"expiration_date":"2030-02-28","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001127602-21-019715","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1690927/000112760221019715/form4.xml","form_type":"4"}},{"id":2672056,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-06-11T20:14:03.000Z","date":"2021-06-09","kind":"sale","acquired":false,"shares":5000,"price":212.3,"value":1061500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 5, 2021."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001127602-21-019715","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1690927/000112760221019715/form4.xml","form_type":"4"}},{"id":2672055,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-06-11T20:14:03.000Z","date":"2021-06-09","kind":"exercise","acquired":true,"shares":5000,"price":25.93,"value":129650.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 5, 2021."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001127602-21-019715","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690927/000112760221019715/form4.xml","form_type":"4"}},{"id":2683374,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-03T20:47:26.000Z","date":"2021-06-02","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 5, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of this option vested and became exercisable on February 28, 2021 with the remainder vesting in twelve (12) equal quarterly installments thereafter."}],"balance_after":141120,"derivative":{"exercise_price":25.93,"expiration_date":"2030-02-28","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001127602-21-019005","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1690927/000112760221019005/form4.xml","form_type":"4"}},{"id":2683373,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-06-03T20:47:26.000Z","date":"2021-06-02","kind":"sale","acquired":false,"shares":5000,"price":183.9,"value":919500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 5, 2021."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001127602-21-019005","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1690927/000112760221019005/form4.xml","form_type":"4"}},{"id":2683372,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-06-03T20:47:26.000Z","date":"2021-06-02","kind":"exercise","acquired":true,"shares":5000,"price":25.93,"value":129650.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 5, 2021."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001127602-21-019005","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690927/000112760221019005/form4.xml","form_type":"4"}},{"id":2693459,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-27T20:11:00.000Z","date":"2021-05-26","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 5, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of this option vested and became exercisable on February 28, 2021 with the remainder vesting in twelve (12) equal quarterly installments thereafter."}],"balance_after":146120,"derivative":{"exercise_price":25.93,"expiration_date":"2030-02-28","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001127602-21-018169","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1690927/000112760221018169/form4.xml","form_type":"4"}},{"id":2693458,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-05-27T20:11:00.000Z","date":"2021-05-26","kind":"sale","acquired":false,"shares":5000,"price":168.7,"value":843500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 5, 2021."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001127602-21-018169","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1690927/000112760221018169/form4.xml","form_type":"4"}},{"id":2693457,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-05-27T20:11:00.000Z","date":"2021-05-26","kind":"exercise","acquired":true,"shares":5000,"price":25.93,"value":129650.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 5, 2021."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001127602-21-018169","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690927/000112760221018169/form4.xml","form_type":"4"}},{"id":2703273,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-20T21:14:43.000Z","date":"2021-05-19","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 5, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of this option vested and became exercisable on February 28, 2021 with the remainder vesting in twelve (12) equal quarterly installments thereafter."}],"balance_after":151120,"derivative":{"exercise_price":25.93,"expiration_date":"2030-02-28","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001127602-21-017657","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1690927/000112760221017657/form4.xml","form_type":"4"}},{"id":2703272,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-05-20T21:14:43.000Z","date":"2021-05-19","kind":"sale","acquired":false,"shares":5000,"price":155.74,"value":778700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 5, 2021."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001127602-21-017657","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1690927/000112760221017657/form4.xml","form_type":"4"}},{"id":2703271,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-05-20T21:14:43.000Z","date":"2021-05-19","kind":"exercise","acquired":true,"shares":5000,"price":25.93,"value":129650.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 5, 2021."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001127602-21-017657","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690927/000112760221017657/form4.xml","form_type":"4"}},{"id":2714531,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-13T20:03:52.000Z","date":"2021-05-12","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 5, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of this option vested and became exercisable on February 28, 2021 with the remainder vesting in twelve (12) equal quarterly installments thereafter."}],"balance_after":156120,"derivative":{"exercise_price":25.93,"expiration_date":"2030-02-28","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001127602-21-016538","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1690927/000112760221016538/form4.xml","form_type":"4"}},{"id":2714530,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-05-13T20:03:52.000Z","date":"2021-05-12","kind":"sale","acquired":false,"shares":5000,"price":154.11,"value":770550.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 5, 2021."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001127602-21-016538","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1690927/000112760221016538/form4.xml","form_type":"4"}},{"id":2714529,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-05-13T20:03:52.000Z","date":"2021-05-12","kind":"exercise","acquired":true,"shares":5000,"price":25.93,"value":129650.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 5, 2021."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001127602-21-016538","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690927/000112760221016538/form4.xml","form_type":"4"}},{"id":2718686,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-11T20:12:52.000Z","date":"2021-05-10","kind":"exercise","acquired":false,"shares":3670,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"229,358 of the options will vest over 4 years (25% on the first anniversary of the grant date of October 3, 2017, then quarterly for the next 3 years). 137,614 of the options will vest over 5 years (25% on the second anniversary of the grant date of October 3, 2017, then quarterly for the next 3 years). 91,743 of the options will vest over 6 years (25% on the third anniversary of the grant date of October 3, 2017, then quarterly for the next 3 years)."}],"balance_after":137612,"derivative":{"exercise_price":12.21,"expiration_date":"2027-10-03","underlying":"Common Stock","underlying_shares":3670},"source":{"system":"sec-edgar","filing":"0001127602-21-016223","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1690927/000112760221016223/form4.xml","form_type":"4"}},{"id":2718685,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-05-11T20:12:52.000Z","date":"2021-05-10","kind":"sale","acquired":false,"shares":200,"price":163.12,"value":32624.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price.  The shares were sold in multiple transactions at prices ranging from $163.00 to $163.25.  Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001127602-21-016223","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1690927/000112760221016223/form4.xml","form_type":"4"}},{"id":2718684,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-05-11T20:12:52.000Z","date":"2021-05-10","kind":"sale","acquired":false,"shares":100,"price":161.64,"value":16164.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020."}],"balance_after":200,"source":{"system":"sec-edgar","filing":"0001127602-21-016223","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1690927/000112760221016223/form4.xml","form_type":"4"}},{"id":2718683,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-05-11T20:12:52.000Z","date":"2021-05-10","kind":"sale","acquired":false,"shares":200,"price":159.63,"value":31926.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price.  The shares were sold in multiple transactions at prices ranging from $159.58 to $159.68.  Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":300,"source":{"system":"sec-edgar","filing":"0001127602-21-016223","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1690927/000112760221016223/form4.xml","form_type":"4"}},{"id":2718682,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-05-11T20:12:52.000Z","date":"2021-05-10","kind":"sale","acquired":false,"shares":1585,"price":158.88,"value":251824.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price.  The shares were sold in multiple transactions at prices ranging from $158.28 to $159.27.  Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":500,"source":{"system":"sec-edgar","filing":"0001127602-21-016223","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1690927/000112760221016223/form4.xml","form_type":"4"}},{"id":2718681,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-05-11T20:12:52.000Z","date":"2021-05-10","kind":"sale","acquired":false,"shares":985,"price":157.48,"value":155117.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price.  The shares were sold in multiple transactions at prices ranging from $157.03 to $158.01.  Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":2085,"source":{"system":"sec-edgar","filing":"0001127602-21-016223","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1690927/000112760221016223/form4.xml","form_type":"4"}},{"id":2718680,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-05-11T20:12:52.000Z","date":"2021-05-10","kind":"sale","acquired":false,"shares":600,"price":156.6,"value":93960.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $155.99 to $156.87. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":3070,"source":{"system":"sec-edgar","filing":"0001127602-21-016223","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1690927/000112760221016223/form4.xml","form_type":"4"}},{"id":2718679,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-05-11T20:12:52.000Z","date":"2021-05-10","kind":"exercise","acquired":true,"shares":3670,"price":12.21,"value":44810.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020."}],"balance_after":3670,"source":{"system":"sec-edgar","filing":"0001127602-21-016223","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690927/000112760221016223/form4.xml","form_type":"4"}},{"id":2730253,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-04T20:56:42.000Z","date":"2021-05-03","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"229,358 of the options will vest over 4 years (25% on the first anniversary of the grant date of October 3, 2017, then quarterly for the next 3 years). 137,614 of the options will vest over 5 years (25% on the second anniversary of the grant date of October 3, 2017, then quarterly for the next 3 years). 91,743 of the options will vest over 6 years (25% on the third anniversary of the grant date of October 3, 2017, then quarterly for the next 3 years)."}],"balance_after":141282,"derivative":{"exercise_price":12.21,"expiration_date":"2027-10-03","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001127602-21-015257","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1690927/000112760221015257/form4.xml","form_type":"4"}},{"id":2730252,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-05-04T20:56:42.000Z","date":"2021-05-03","kind":"sale","acquired":false,"shares":916,"price":188,"value":172208.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price.  The shares were sold in multiple transactions at prices ranging from $187.69 to $188.68.  Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001127602-21-015257","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1690927/000112760221015257/form4.xml","form_type":"4"}},{"id":2730251,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-05-04T20:56:42.000Z","date":"2021-05-03","kind":"sale","acquired":false,"shares":1924,"price":187.1,"value":359980.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price.  The shares were sold in multiple transactions at prices ranging from $186.65 to $187.61.  Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":916,"source":{"system":"sec-edgar","filing":"0001127602-21-015257","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1690927/000112760221015257/form4.xml","form_type":"4"}},{"id":2730250,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-05-04T20:56:42.000Z","date":"2021-05-03","kind":"sale","acquired":false,"shares":1089,"price":186.04,"value":202597.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price.  The shares were sold in multiple transactions at prices ranging from $185.54 to $186.54  Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":2840,"source":{"system":"sec-edgar","filing":"0001127602-21-015257","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1690927/000112760221015257/form4.xml","form_type":"4"}},{"id":2730249,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-05-04T20:56:42.000Z","date":"2021-05-03","kind":"sale","acquired":false,"shares":800,"price":184.77,"value":147816.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price.  The shares were sold in multiple transactions at prices ranging from $184.21 to $185.10.  Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":3929,"source":{"system":"sec-edgar","filing":"0001127602-21-015257","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1690927/000112760221015257/form4.xml","form_type":"4"}},{"id":2730248,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-05-04T20:56:42.000Z","date":"2021-05-03","kind":"sale","acquired":false,"shares":271,"price":183.42,"value":49706.82,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  The shares were sold in multiple transactions at prices ranging from $183.19 to $183.59.  Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":4729,"source":{"system":"sec-edgar","filing":"0001127602-21-015257","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1690927/000112760221015257/form4.xml","form_type":"4"}},{"id":2730247,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-05-04T20:56:42.000Z","date":"2021-05-03","kind":"exercise","acquired":true,"shares":5000,"price":12.21,"value":61050.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001127602-21-015257","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690927/000112760221015257/form4.xml","form_type":"4"}},{"id":2738552,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-27T20:17:41.000Z","date":"2021-04-26","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"229,358 of the options will vest over 4 years (25% on the first anniversary of the grant date of October 3, 2017, then quarterly for the next 3 years). 137,614 of the options will vest over 5 years (25% on the second anniversary of the grant date of October 3, 2017, then quarterly for the next 3 years). 91,743 of the options will vest over 6 years (25% on the third anniversary of the grant date of October 3, 2017, then quarterly for the next 3 years)."}],"balance_after":146282,"derivative":{"exercise_price":12.21,"expiration_date":"2027-10-03","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001127602-21-014509","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1690927/000112760221014509/form4.xml","form_type":"4"}},{"id":2738551,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-04-27T20:17:41.000Z","date":"2021-04-26","kind":"sale","acquired":false,"shares":100,"price":179.37,"value":17937.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001127602-21-014509","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1690927/000112760221014509/form4.xml","form_type":"4"}},{"id":2738550,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-04-27T20:17:41.000Z","date":"2021-04-26","kind":"sale","acquired":false,"shares":1829,"price":178.51,"value":326494.79,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted average price.  The shares were sold in multiple transactions at prices ranging from $178.06 to $178.90.  Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":100,"source":{"system":"sec-edgar","filing":"0001127602-21-014509","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1690927/000112760221014509/form4.xml","form_type":"4"}},{"id":2738549,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-04-27T20:17:41.000Z","date":"2021-04-26","kind":"sale","acquired":false,"shares":900,"price":177.41,"value":159669.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price.  The shares were sold in multiple transactions at prices ranging from $176.92 to $177.92.  Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":1929,"source":{"system":"sec-edgar","filing":"0001127602-21-014509","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1690927/000112760221014509/form4.xml","form_type":"4"}},{"id":2738548,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-04-27T20:17:41.000Z","date":"2021-04-26","kind":"sale","acquired":false,"shares":551,"price":175.97,"value":96959.47,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price.  The shares were sold in multiple transactions at prices ranging from $175.70 to $176.64.  Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":2829,"source":{"system":"sec-edgar","filing":"0001127602-21-014509","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1690927/000112760221014509/form4.xml","form_type":"4"}},{"id":2738547,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-04-27T20:17:41.000Z","date":"2021-04-26","kind":"sale","acquired":false,"shares":400,"price":175.03,"value":70012.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price.  The shares were sold in multiple transactions at prices ranging from $174.54 to $175.40.  Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":3380,"source":{"system":"sec-edgar","filing":"0001127602-21-014509","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1690927/000112760221014509/form4.xml","form_type":"4"}},{"id":2738546,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-04-27T20:17:41.000Z","date":"2021-04-26","kind":"sale","acquired":false,"shares":200,"price":173.03,"value":34606.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price.  The shares were sold in multiple transactions at prices ranging from $172.66 to $173.39.  Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":3780,"source":{"system":"sec-edgar","filing":"0001127602-21-014509","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1690927/000112760221014509/form4.xml","form_type":"4"}},{"id":2738545,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-04-27T20:17:41.000Z","date":"2021-04-26","kind":"sale","acquired":false,"shares":1,"price":171.65,"value":171.65,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020."}],"balance_after":3980,"source":{"system":"sec-edgar","filing":"0001127602-21-014509","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1690927/000112760221014509/form4.xml","form_type":"4"}},{"id":2738544,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-04-27T20:17:41.000Z","date":"2021-04-26","kind":"sale","acquired":false,"shares":439,"price":171.05,"value":75090.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price.  The shares were sold in multiple transactions at prices ranging from $170.61 to $171.58.  Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":3981,"source":{"system":"sec-edgar","filing":"0001127602-21-014509","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1690927/000112760221014509/form4.xml","form_type":"4"}},{"id":2738543,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-04-27T20:17:41.000Z","date":"2021-04-26","kind":"sale","acquired":false,"shares":580,"price":169.87,"value":98524.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  The shares were sold in multiple transactions at prices ranging from $169.46 to $170.24.  Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":4420,"source":{"system":"sec-edgar","filing":"0001127602-21-014509","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1690927/000112760221014509/form4.xml","form_type":"4"}},{"id":2738542,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-04-27T20:17:41.000Z","date":"2021-04-26","kind":"exercise","acquired":true,"shares":5000,"price":12.21,"value":61050.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001127602-21-014509","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690927/000112760221014509/form4.xml","form_type":"4"}},{"id":2744020,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-20T20:09:36.000Z","date":"2021-04-19","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"229,358 of the options will vest over 4 years (25% on the first anniversary of the grant date of October 3, 2017, then quarterly for the next 3 years). 137,614 of the options will vest over 5 years (25% on the second anniversary of the grant date of October 3, 2017, then quarterly for the next 3 years). 91,743 of the options will vest over 6 years (25% on the third anniversary of the grant date of October 3, 2017, then quarterly for the next 3 years)."}],"balance_after":151282,"derivative":{"exercise_price":12.21,"expiration_date":"2027-10-03","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001127602-21-014113","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1690927/000112760221014113/form4.xml","form_type":"4"}},{"id":2744019,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-04-20T20:09:36.000Z","date":"2021-04-19","kind":"sale","acquired":false,"shares":100,"price":167.56,"value":16756.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001127602-21-014113","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1690927/000112760221014113/form4.xml","form_type":"4"}},{"id":2744018,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-04-20T20:09:36.000Z","date":"2021-04-19","kind":"sale","acquired":false,"shares":700,"price":166.31,"value":116417.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price.  The shares were sold in multiple transactions at prices ranging from $166.07 to $166.51.  Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":100,"source":{"system":"sec-edgar","filing":"0001127602-21-014113","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1690927/000112760221014113/form4.xml","form_type":"4"}},{"id":2744017,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-04-20T20:09:36.000Z","date":"2021-04-19","kind":"sale","acquired":false,"shares":462,"price":165.04,"value":76248.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price.  The shares were sold in multiple transactions at prices ranging from $164.71 to $165.36.  Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":800,"source":{"system":"sec-edgar","filing":"0001127602-21-014113","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1690927/000112760221014113/form4.xml","form_type":"4"}},{"id":2744016,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-04-20T20:09:36.000Z","date":"2021-04-19","kind":"sale","acquired":false,"shares":500,"price":163.89,"value":81945.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price.  The shares were sold in multiple transactions at prices ranging from $163.50 to $164.12.  Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":1262,"source":{"system":"sec-edgar","filing":"0001127602-21-014113","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1690927/000112760221014113/form4.xml","form_type":"4"}},{"id":2744015,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-04-20T20:09:36.000Z","date":"2021-04-19","kind":"sale","acquired":false,"shares":1250,"price":162.65,"value":203312.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price.  The shares were sold in multiple transactions at prices ranging from $162.22 to $163.13.  Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":1762,"source":{"system":"sec-edgar","filing":"0001127602-21-014113","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1690927/000112760221014113/form4.xml","form_type":"4"}},{"id":2744014,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-04-20T20:09:36.000Z","date":"2021-04-19","kind":"sale","acquired":false,"shares":1332,"price":161.62,"value":215277.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price.  The shares were sold in multiple transactions at prices ranging from $161.14 to $162.11.  Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":3012,"source":{"system":"sec-edgar","filing":"0001127602-21-014113","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1690927/000112760221014113/form4.xml","form_type":"4"}},{"id":2744013,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-04-20T20:09:36.000Z","date":"2021-04-19","kind":"sale","acquired":false,"shares":656,"price":160.48,"value":105274.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  The shares were sold in multiple transactions at prices ranging from $160.04 to $160.88.  Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":4344,"source":{"system":"sec-edgar","filing":"0001127602-21-014113","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1690927/000112760221014113/form4.xml","form_type":"4"}},{"id":2744012,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-04-20T20:09:36.000Z","date":"2021-04-19","kind":"exercise","acquired":true,"shares":5000,"price":12.21,"value":61050.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001127602-21-014113","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690927/000112760221014113/form4.xml","form_type":"4"}},{"id":2750459,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-13T20:14:16.000Z","date":"2021-04-12","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"229,358 of the options will vest over 4 years (25% on the first anniversary of the grant date of October 3, 2017, then quarterly for the next 3 years). 137,614 of the options will vest over 5 years (25% on the second anniversary of the grant date of October 3, 2017, then quarterly for the next 3 years). 91,743 of the options will vest over 6 years (25% on the third anniversary of the grant date of October 3, 2017, then quarterly for the next 3 years)."}],"balance_after":156282,"derivative":{"exercise_price":12.21,"expiration_date":"2027-10-03","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001127602-21-013695","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1690927/000112760221013695/form4.xml","form_type":"4"}},{"id":2750458,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-04-13T20:14:16.000Z","date":"2021-04-12","kind":"sale","acquired":false,"shares":100,"price":143.09,"value":14309.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001127602-21-013695","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1690927/000112760221013695/form4.xml","form_type":"4"}},{"id":2750457,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-04-13T20:14:16.000Z","date":"2021-04-12","kind":"sale","acquired":false,"shares":400,"price":141.79,"value":56716.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price.  The shares were sold in multiple transactions at prices ranging from $141.61 to $142.26.  Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":100,"source":{"system":"sec-edgar","filing":"0001127602-21-013695","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1690927/000112760221013695/form4.xml","form_type":"4"}},{"id":2750456,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-04-13T20:14:16.000Z","date":"2021-04-12","kind":"sale","acquired":false,"shares":413,"price":140.22,"value":57910.86,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price.  The shares were sold in multiple transactions at prices ranging from $139.94 to $140.58.  Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":500,"source":{"system":"sec-edgar","filing":"0001127602-21-013695","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1690927/000112760221013695/form4.xml","form_type":"4"}},{"id":2750455,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-04-13T20:14:16.000Z","date":"2021-04-12","kind":"sale","acquired":false,"shares":1824,"price":139.38,"value":254229.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price.  The shares were sold in multiple transactions at prices ranging from $138.86 to $139.77.  Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":913,"source":{"system":"sec-edgar","filing":"0001127602-21-013695","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1690927/000112760221013695/form4.xml","form_type":"4"}},{"id":2750454,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-04-13T20:14:16.000Z","date":"2021-04-12","kind":"sale","acquired":false,"shares":1400,"price":138.06,"value":193284.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price.  The shares were sold in multiple transactions at prices ranging from $137.70 to $138.58.  Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":2737,"source":{"system":"sec-edgar","filing":"0001127602-21-013695","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1690927/000112760221013695/form4.xml","form_type":"4"}},{"id":2750453,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-04-13T20:14:16.000Z","date":"2021-04-12","kind":"sale","acquired":false,"shares":863,"price":137.16,"value":118369.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  The shares were sold in multiple transactions at prices ranging from $136.66 to $137.64.  Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":4137,"source":{"system":"sec-edgar","filing":"0001127602-21-013695","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1690927/000112760221013695/form4.xml","form_type":"4"}},{"id":2750452,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-04-13T20:14:16.000Z","date":"2021-04-12","kind":"exercise","acquired":true,"shares":5000,"price":12.21,"value":61050.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001127602-21-013695","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690927/000112760221013695/form4.xml","form_type":"4"}},{"id":2755774,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-06T20:13:49.000Z","date":"2021-04-05","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"229,358 of the options will vest over 4 years (25% on the first anniversary of the grant date of October 3, 2017, then quarterly for the next 3 years). 137,614 of the options will vest over 5 years (25% on the second anniversary of the grant date of October 3, 2017, then quarterly for the next 3 years). 91,743 of the options will vest over 6 years (25% on the third anniversary of the grant date of October 3, 2017, then quarterly for the next 3 years)."}],"balance_after":161282,"derivative":{"exercise_price":12.21,"expiration_date":"2027-10-03","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001127602-21-013342","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1690927/000112760221013342/form4.xml","form_type":"4"}},{"id":2755773,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-04-06T20:13:49.000Z","date":"2021-04-05","kind":"sale","acquired":false,"shares":1150,"price":130.95,"value":150592.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price.  The shares were sold in multiple transactions at prices ranging from $130.58 to $131.51.  Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001127602-21-013342","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1690927/000112760221013342/form4.xml","form_type":"4"}},{"id":2755772,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-04-06T20:13:49.000Z","date":"2021-04-05","kind":"sale","acquired":false,"shares":2426,"price":129.96,"value":315282.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price.  The shares were sold in multiple transactions at prices ranging from $129.47 to $130.35.  Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":2574,"source":{"system":"sec-edgar","filing":"0001127602-21-013342","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1690927/000112760221013342/form4.xml","form_type":"4"}},{"id":2755771,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-04-06T20:13:49.000Z","date":"2021-04-05","kind":"sale","acquired":false,"shares":814,"price":128.65,"value":104721.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price.  The shares were sold in multiple transactions at prices ranging from $128.33 to $129.08.  Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":1150,"source":{"system":"sec-edgar","filing":"0001127602-21-013342","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1690927/000112760221013342/form4.xml","form_type":"4"}},{"id":2755770,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-04-06T20:13:49.000Z","date":"2021-04-05","kind":"sale","acquired":false,"shares":610,"price":127.76,"value":77933.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  The shares were sold in multiple transactions at prices ranging from $127.21 to $128.14.  Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":1964,"source":{"system":"sec-edgar","filing":"0001127602-21-013342","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1690927/000112760221013342/form4.xml","form_type":"4"}},{"id":2755769,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-04-06T20:13:49.000Z","date":"2021-04-05","kind":"exercise","acquired":true,"shares":5000,"price":12.21,"value":61050.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001127602-21-013342","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690927/000112760221013342/form4.xml","form_type":"4"}},{"id":2774889,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-23T20:19:42.000Z","date":"2021-03-22","kind":"exercise","acquired":false,"shares":1199,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"25% of this option vested and became exercisable on March 8, 2020 with the remainder vesting in 12 equal quarterly installments thereafter."}],"balance_after":169599,"derivative":{"exercise_price":20.93,"expiration_date":"2029-03-08","underlying":"Common Stock","underlying_shares":1199},"source":{"system":"sec-edgar","filing":"0001127602-21-011821","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1690927/000112760221011821/form4.xml","form_type":"4"}},{"id":2774888,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-03-23T20:19:42.000Z","date":"2021-03-22","kind":"sale","acquired":false,"shares":61,"price":147.5,"value":8997.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001127602-21-011821","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1690927/000112760221011821/form4.xml","form_type":"4"}},{"id":2774887,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-03-23T20:19:42.000Z","date":"2021-03-22","kind":"sale","acquired":false,"shares":290,"price":146.46,"value":42473.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price.  The shares were sold in multiple transactions at prices ranging from $146.15 to $146.95.  Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":61,"source":{"system":"sec-edgar","filing":"0001127602-21-011821","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1690927/000112760221011821/form4.xml","form_type":"4"}},{"id":2774886,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-03-23T20:19:42.000Z","date":"2021-03-22","kind":"sale","acquired":false,"shares":227,"price":145.47,"value":33021.69,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price.  The shares were sold in multiple transactions at prices ranging from $144.89 to $145.85.  Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":351,"source":{"system":"sec-edgar","filing":"0001127602-21-011821","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1690927/000112760221011821/form4.xml","form_type":"4"}},{"id":2774885,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-03-23T20:19:42.000Z","date":"2021-03-22","kind":"sale","acquired":false,"shares":366,"price":144.06,"value":52725.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price.  The shares were sold in multiple transactions at prices ranging from $143.63 to $144.60.  Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":578,"source":{"system":"sec-edgar","filing":"0001127602-21-011821","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1690927/000112760221011821/form4.xml","form_type":"4"}},{"id":2774884,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-03-23T20:19:42.000Z","date":"2021-03-22","kind":"sale","acquired":false,"shares":255,"price":142.83,"value":36421.65,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  The shares were sold in multiple transactions at prices ranging from $142.23 to $143.22.  Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":944,"source":{"system":"sec-edgar","filing":"0001127602-21-011821","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1690927/000112760221011821/form4.xml","form_type":"4"}},{"id":2774883,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-03-23T20:19:42.000Z","date":"2021-03-22","kind":"exercise","acquired":true,"shares":1199,"price":20.93,"value":25095.07,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020."}],"balance_after":1199,"source":{"system":"sec-edgar","filing":"0001127602-21-011821","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690927/000112760221011821/form4.xml","form_type":"4"}}],"next_cursor":"2021-03-23T20:19:42.000000Z,2774883"}